Literature DB >> 33629193

Single procedural outcomes in the setting of percutaneous ablation for persistent atrial fibrillation: a propensity-matched score comparison between different strategies.

Antonio Bisignani1,2, Federico Cecchini1, Giacomo Mugnai1, Ingrid Overeinder1, Juan Sieira1, Thiago Guimarães Osório1, Vincenzo Miraglia1, Cinzia Monaco1, Dimitrios Sofianos1, Serge Boveda1, Gezim Bala1, Erwin Ströker1, Gaetano Paparella1, Sjoerd W Westra3, Marc A Brouwer3, Pedro Brugada1, Carlo de Asmundis1, Gian-Battista Chierchia4.   

Abstract

BACKGROUND: Catheter ablation for persistent atrial fibrillation (persAF) is associated with less favorable outcomes than for paroxysmal AF. To improve success rates, left atrial (LA) substrate modification is frequently performed in addition to pulmonary vein isolation (PVI). The purpose of the study was to compare 4 different ablation approaches using radiofrequency catheter ablation (RFCA) or cryoballoon ablation (CB-A) for persAF and to evaluate the respective outcomes on a midterm follow-up of 12 months.
METHODS: We did a propensity score-matched comparison of 30 patients undergoing PVI + LA posterior wall isolation (LAPWI) with CB-A, 30 patients who underwent PVI + linear ablation (roof and mitral lines) using RFCA, 60 patients with PVI alone using CB-A, and 60 patients who had PVI alone using RFCA. The endpoint was recurrence of documented atrial tachyarrhythmias (ATas) > 30 s at 1-year follow-up.
RESULTS: After 12 months, freedom from ATas after a single procedure was 83.3% in the PVI + LAPWI group, 46.7% in the PVI + linear ablation group, 58.3% in the PVI-alone CB-A group, and 61.6% PVI-alone RFCA (p = 0.03). Moreover, freedom from ATas was significantly higher comparing the PVI + LAPWI group with each of the other groups.
CONCLUSIONS: In this propensity-matched comparison of strategies for persAF, LAPW ablation in addition to PVI with CB-A seems to improve 1-year outcome in comparison to PVI + linear ablation using RFCA and to PVI alone using RFCA or CB-A. Randomized comparisons are eagerly awaited.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cryoballoon; Left atrial posterior wall ablation; Persistent atrial fibrillation; Pulmonary vein isolation; Radiofrequency ablation

Mesh:

Year:  2021        PMID: 33629193     DOI: 10.1007/s10840-021-00968-2

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  1 in total

1.  Cryoballoon ablation of persistent atrial fibrillation: feasibility and safety of left atrial roof ablation with generation of conduction block in addition to antral pulmonary vein isolation.

Authors:  Malte Kuniss; Harald Greiß; Dmitri Pajitnev; Ersan Akkaya; Nikolas Deubner; Andreas Hain; Lars Bodammer; Alexander Berkowitsch; Gian-Battista Chierchia; Christian W Hamm; Thomas Neumann
Journal:  Europace       Date:  2017-07-01       Impact factor: 5.214

  1 in total
  5 in total

1.  Comparison of cryoballoon and radiofrequency ablation for persistent atrial fibrillation: a systematic review and meta-analysis.

Authors:  Jitae A Kim; Mihail G Chelu
Journal:  J Interv Card Electrophysiol       Date:  2022-09-12       Impact factor: 1.759

2.  Atrial Fibrillation Global Changes after Pulmonary Vein and Posterior Wall Isolation: A Charge Density Mapping Study.

Authors:  Luigi Pannone; Antonio Bisignani; Antonio Sorgente; Anaïs Gauthey; Domenico G Della Rocca; Cinzia Monaco; Wim Bories; Robbert Ramak; Ingrid Overeinder; Gezim Bala; Alexandre Almorad; Saverio Iacopino; Gaetano Paparella; Erwin Ströker; Juan Sieira; Panagiotis Flamée; Pedro Brugada; Mark La Meir; Gian-Battista Chierchia; Carlo De Asmundis
Journal:  J Clin Med       Date:  2022-05-23       Impact factor: 4.964

3.  Repeat procedures for recurrent persistent atrial fibrillation: A propensity-matched score comparison between left atrial linear ablation with radiofrequency and posterior wall isolation with the cryoballoon.

Authors:  Antonio Bisignani; Luigi Pannone; Gezim Bala; Shuichiro Kazawa; Paul Calburean; Ingrid Overeinder; Cinzia Monaco; Felicia Lipartiti; Vincenzo Miraglia; Sergio Rizzi; Maysam Al Housari; Joerelle Mojica; Antanas Strazdas; Thiago Guimarães Osório; Juan Sieira; Saverio Iacopino; Alexandre Almorad; Erwin Ströker; Antonio Sorgente; Pedro Brugada; Carlo de Asmundis; Gian-Battista Chierchia
Journal:  J Arrhythm       Date:  2021-08-10

4.  Long-Term Outcomes of Pulmonary Vein Isolation in Patients With Brugada Syndrome and Paroxysmal Atrial Fibrillation.

Authors:  Antonio Bisignani; Giulio Conte; Luigi Pannone; Juan Sieira; Alvise Del Monte; Felicia Lipartiti; Gezim Bala; Vincenzo Miraglia; Cinzia Monaco; Erwin Ströker; Ingrid Overeinder; Alexandre Almorad; Anaïs Gauthey; Livia Franchetti Pardo; Matthias Raes; Olivier Detriche; Pedro Brugada; Angelo Auricchio; Gian-Battista Chierchia; Carlo de Asmundis
Journal:  J Am Heart Assoc       Date:  2022-07-20       Impact factor: 6.106

5.  Feasibility and safety of left atrial posterior wall isolation with a new Cryoballoon technology in patients with persistent atrial fibrillation.

Authors:  Antonio Bisignani; Luigi Pannone; Vincenzo Miraglia; Juan Sieira; Saverio Iacopino; Gezim Bala; Erwin Ströker; Ingrid Overeinder; Alexandre Almorad; Anaïs Gauthey; Cinzia Monaco; Gaetano Paparella; Thiago Guimarães Osório; Antonio Sorgente; Luc Jordaens; Pedro Brugada; Gian-Battista Chierchia; Carlo de Asmundis
Journal:  Pacing Clin Electrophysiol       Date:  2022-04-07       Impact factor: 1.912

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.